EUVIMEDEUVIMED entdecken
Crossref

Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem

Sei Morinaga, Qinghong Han, Kohei Mizuta, Byung M Kang, Motokazu Sato, Michael Bouvet, Norio Yamamoto, Katsuhiro Hayashi, Hiroaki Kimura, Shinji Miwa, Kentaro Igarashi, Takashi Higuchi und 3 weitere

Anticancer Research · 2024

DOI: 10.21873/anticanres.17203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Sei Morinaga und 14 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc., San Diego, CA, U.S.A. Hauptthemen laut MEDLINE: Trabectedin, Carbon-Sulfur Lyases, Drug Resistance, Neoplasm, Tetrahydroisoquinolines. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TrabectedinCarbon-Sulfur LyasesDrug Resistance, NeoplasmTetrahydroisoquinolinesAntineoplastic Agents, AlkylatingDioxolesRecombinant ProteinsHumansCell Line, TumorSarcomaFibrosarcomaDrug Synergism

Stichwörter der Autor:innen

DNA bindingHoffman effectMethioninasefibrosarcomamethionine addictionmethionine restrictionsynergistic efficacytrabectedin-resistance

Substanzen

TrabectedinCarbon-Sulfur LyasesL-methionine gamma-lyaseTetrahydroisoquinolinesAntineoplastic Agents, AlkylatingDioxolesRecombinant Proteins

Autor:innen und Institutionen

  • AntiCancer Inc., San Diego, CA, U.S.A.
  • Department of Surgery, University of California, San Diego, CA, U.S.A.
  • Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kanazawa University, Kanazawa, Japan.
  • AntiCancer Inc., San Diego, CA, U.S.A.; all@anticancer.com.

Zitieren

APA

Morinaga, S., Han, Q., Mizuta, K., Kang, B. M., Sato, M., Bouvet, M., Yamamoto, N., Hayashi, K., Kimura, H., Miwa, S., Igarashi, K., Higuchi, T., Tsuchiya, H., Demura, S., & Hoffman, R. M. (2024). Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem. Anticancer Research. https://doi.org/10.21873/anticanres.17203

Vancouver

Morinaga S, Han Q, Mizuta K, Kang BM, Sato M, Bouvet M, et al. Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem. Anticancer Research. 2024. doi:10.21873/anticanres.17203

BibTeX
@article{Morinaga2024,
  author = {Morinaga, Sei and Han, Qinghong and Mizuta, Kohei and Kang, Byung M and Sato, Motokazu and Bouvet, Michael and Yamamoto, Norio and Hayashi, Katsuhiro and Kimura, Hiroaki and Miwa, Shinji and Igarashi, Kentaro and Higuchi, Takashi and Tsuchiya, Hiroyuki and Demura, Satoru and Hoffman, Robert M},
  title = {Overcoming High Trabectedin Resistance of Soft-tissue Sarcoma With Recombinant Methioninase: A Potential Solution of a Recalcitrant Clinical Problem},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.17203}
}
Kostenlos starten →